Mechanics of glycerinated muscle fibers using nonnucleoside triphosphate substrates.
We have investigated the ability of the photoaffinity, nonnucleotide ATP analogues, 2-[(4-azido-2-nitrophenyl) amino] ethyl triphosphate (NANTP) and 2-[(4-azido-2-nitrophenyl) amino] propyl triphosphate (PrNANTP), to support active contraction in glycerinated rabbit psoas fibers. At millimolar concentrations, in the absence of calcium, both analogues relaxed fibers. In the presence of calcium, MgNANTP produced isometric tension and stiffness that were one-half to two-thirds the values obtained in MgATP. Maximum shortening velocity and the calcium-activated, myofibrillar catalyzed rate of hydrolysis were approximately the same for MgNANTP as for MgATP. With MgNANTP as the substrate, increasing concentrations of the diphosphate analogue, MgNANDP, inhibited shortening velocity but did not change isometric tension. The addition of increased concentrations of orthophosphate (P) decreased tension while shortening velocity increased. Thus, the effects of the hydrolysis products of NANTP were quite similar to those observed previously for ADP and P in the presence of MgATP. Taken together, these observations show that MgNANTP binds to, and functions in the active site of myosin in a manner quite analogous to MgATP. Thus, the aryl azido group should serve as a valid photoaffinity label for the purine portion of the active site. In contrast, MgPrNANTP, which differs from MgNANTP only in an extra CH2 spacer between the nitrophenyl ring and the triphosphate moiety did not support isometric tension or active shortening in the presence of calcium. Fiber stiffness increased in the presence of calcium and MgPrNANTP, with a calcium-activated, myofibrillar MgPrNANTPase which was about half that obtained with MgATP. Thus, in the presence of MgPrNANTP, cross-bridges appeared to be cycling through states that were attached to actin, but not producing force.
Pate
E
E
Department of Pure and Applied Mathematics, Washington State University, Pullman 99164.
Nakamaye
K L
KL
Franks-Skiba
K
K
Yount
R G
RG
Cooke
R
R
D000255:Adenosine Triphosphate / Q000378:metabolism / Q000494:pharmacology; D000345:Affinity Labels; D000818:Animals; D001386:Azides / Q000378:metabolism / Q000494:pharmacology; D001696:Biomechanical Phenomena; D055592:Biophysical Phenomena; D001703:Biophysics; D005990:Glycerol; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D009132:Muscles / Q000378:metabolism; D011817:Rabbits
D000345:Affinity Labels; D001386:Azides; C069394:2-((4-azido-2-nitrophenyl)amino)propyl triphosphate; D000255:Adenosine Triphosphate; C047568:2-((4-azido-2-nitrophenyl)amino)ethyl triphosphate; D005990:Glycerol